Cellectis S.A.
CLLS
$1.26
$0.0352.87%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 100.97% | 78.03% | |||
| Total Other Revenue | 28.36% | -26.80% | |||
| Total Revenue | 89.95% | 46.24% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 89.95% | 46.24% | |||
| SG&A Expenses | 33.10% | -23.94% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 74.49% | -1,860.00% | |||
| Total Operating Expenses | 7.89% | -2.48% | |||
| Operating Income | 37.42% | 17.63% | |||
| Income Before Tax | 9.22% | -573.20% | |||
| Income Tax Expenses | 69.43% | 26.34% | |||
| Earnings from Continuing Operations | 8.76% | -547.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.76% | -547.81% | |||
| EBIT | 37.42% | 17.63% | |||
| EBITDA | 44.72% | 21.08% | |||
| EPS Basic | 18.10% | -457.76% | |||
| Normalized Basic EPS | 31.96% | -478.42% | |||
| EPS Diluted | 18.10% | -87.47% | |||
| Normalized Diluted EPS | 31.96% | -643.25% | |||
| Average Basic Shares Outstanding | 11.40% | 25.12% | |||
| Average Diluted Shares Outstanding | 11.40% | -12.84% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
